The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Immune gene signatures and integrative spatially-resolved digital profiling of prognostic biomarkers for mesothelioma.
 
Sarah Elizabeth Church
No Relationships to Disclose
 
Carmen Ballesteros-Merino
No Relationships to Disclose
 
Amy H Sullivan
Employment - NanoString Technologies
Stock and Other Ownership Interests - NanoString Technologies
Research Funding - Merck; NanoString Technologies
 
Andrew M White
No Relationships to Disclose
 
Michael D Bailey
No Relationships to Disclose
 
Shawn M Jensen
No Relationships to Disclose
 
John R Handy
No Relationships to Disclose
 
Rachel E. Sanborn
Honoraria - AstraZeneca
Consulting or Advisory Role - Abbvie; Amgen; ARIAD; AstraZeneca; Celldex; Genentech/Roche; Peregrine Pharmaceuticals; Roche/Genentech; Seagen; Takeda
Research Funding - Bristol-Myers Squibb (Inst); MedImmune (Inst); Merck
Travel, Accommodations, Expenses - Five Prime Therapeutics; Janssen Oncology
 
Carlo Bruno Bifulco
Consulting or Advisory Role - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb
Patents, Royalties, Other Intellectual Property - 32898 US2 - U.S. Patent Application No. 15/910972 filed March 2, 2018
 
Sarah Warren
Employment - NanoString Technologies
Stock and Other Ownership Interests - NanoString Technologies
Consulting or Advisory Role - Roche
Travel, Accommodations, Expenses - Roche
 
Joseph M Beechem
No Relationships to Disclose
 
Bernard A. Fox
Employment - UbiVac; UbiVac (I)
Leadership - UbiVac
Stock and Other Ownership Interests - PrimeVax; UbiVac
Honoraria - Janssen Biotech; Nodality
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Celldex; Definiens; Macrogenics; MedImmune; OncoSec
Research Funding - Akoya Biosciences; Bristol-Myers Squibb; DEfiniens; Janssen Biotech; Macrogenics; MedImmune (Inst); Merck; NanoString Technologies; OncoSec; Perkin Elmer; Shimadzu; Viralytics
Patents, Royalties, Other Intellectual Property - Patent around the DPV-001 cancer vaccine. This patent is owned by the Providence Health System and licensed to UbiVac
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Definiens; Definiens; NanoString Technologies